---
title: "Travoprost - Ocular hypertension"
sidebar: mydoc_sidebar
permalink: travoprostocularhypertension.html
toc: false 
---

{% include image.html url="images/travoprostocularhypertension.png" file="travoprostocularhypertension.png" alt="travoprostocularhypertension" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069557 | Travoprost | Drug |
| UniProt:P43088 | Prostaglandin F2-alpha receptor | Protein |
| GO:0008237 | Metallopeptidase activity | BiologicalProcess |
| GO:0031012 | Extracellular matrix | CellularComponent |
| UBERON:0001796 | Aqueous humor of eyeball | GrossAnatomicalStructure |
| MESH:D009798 | Ocular hypertension | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Travoprost | INCREASES ACTIVITY OF | Prostaglandin F2-Alpha Receptor |
| Prostaglandin F2-Alpha Receptor | POSITIVELY REGULATES | Metallopeptidase Activity |
| Metallopeptidase Activity | DECREASES ABUNDANCE OF | Extracellular Matrix |
| Extracellular Matrix | POSITIVELY CORRELATED WITH | Aqueous Humor Of Eyeball |
| Aqueous Humor Of Eyeball | POSITIVELY CORRELATED WITH | Ocular Hypertension |
|---------|-----------|---------|

Comment: Travoprost, an isopropyl ester prodrug,that is rapidly hydrolyzed by esterases in the cornea to its biologically active free acid.

Reference: [https://go.drugbank.com/drugs/DB00287#mechanism-of-action](https://go.drugbank.com/drugs/DB00287#mechanism-of-action){:target="_blank"}